A. Von-rossum, I. Laher, and J. Choy, Immune-Mediated Vascular Injury and Dysfunction in Transplant Arteriosclerosis, Frontiers in Immunology, vol.9, issue.2007, 2014.
DOI : 10.1038/nrrheum.2013.161

J. Sellares, D. De-freitas, M. Mengel, J. Reeve, G. Einecke et al., Understanding the Causes of Kidney Transplant Failure: The Dominant Role of Antibody-Mediated Rejection and Nonadherence, American Journal of Transplantation, vol.10, issue.2, pp.388-99, 2012.
DOI : 10.1111/j.1600-6143.2011.03840.x

L. Walsh and R. Dinavahi, Current unmet needs in renal transplantation: a review of challenges and therapeutics, Front BiosciElite Ed), vol.8, pp.1-14, 2016.

G. Einecke, B. Sis, J. Reeve, M. Mengel, P. Campbell et al., Antibody-Mediated Microcirculation Injury Is the Major Cause of Late Kidney Transplant Failure, American Journal of Transplantation, vol.70, issue.11, pp.2520-2551, 2009.
DOI : 10.1111/j.1600-6143.2009.02799.x

P. Halloran, J. Reeve, A. Pereira, L. Hidalgo, and K. Famulski, Antibody-mediated rejection, T cell???mediated rejection, and the injury-repair response: new insights from the Genome Canada studies of kidney transplant biopsies, Kidney International, vol.85, issue.2, pp.258-64, 2014.
DOI : 10.1038/ki.2013.300

C. Nguan, Antibody-mediated Vascular Rejection of Kidney Allografts: A Population-based Study, Urology, vol.82, issue.3, pp.503-507, 2013.
DOI : 10.1016/j.urology.2013.04.003

B. Nankivell, Antibody-mediated vascular rejection: relation to causation, The Lancet, vol.381, issue.9863, pp.275-282, 2013.
DOI : 10.1016/S0140-6736(12)61577-3

C. Lefaucheur, A. Loupy, D. Vernerey, J. Duong-van-huyen, C. Suberbielle et al., Antibody-mediated vascular rejection of kidney allografts: a population-based study, The Lancet, vol.381, issue.9863, pp.313-322, 2013.
DOI : 10.1016/S0140-6736(12)61265-3

M. Hickey, N. Valenzuela, and E. Reed, Alloantibody Generation and Effector Function Following Sensitization to Human Leukocyte Antigen, Frontiers in Immunology, vol.68, issue.4, 2016.
DOI : 10.1111/j.1523-1755.2005.00606.x

URL : http://doi.org/10.3389/fimmu.2016.00030

I. Torres, M. Salcedo, F. Moreso, J. Sellares, E. Castella et al., Comparing transplant glomerulopathy in the absence of C4d deposition and donor-specific antibodies to chronic antibody-mediated rejection, Clinical Transplantation, vol.12, issue.Suppl 1, pp.1148-54, 2014.
DOI : 10.1111/ctr.12433

W. Hanf, C. Bonder, and P. Coates, Transplant Glomerulopathy: The Interaction of HLA Antibodies and Endothelium, Journal of Immunology Research, vol.8, issue.11, p.549315, 2014.
DOI : 10.1056/NEJMoa061648

A. Loupy, G. Hill, C. Suberbielle, D. Charron, D. Anglicheau et al., Significance of C4d Banff Scores in Early Protocol Biopsies of Kidney Transplant Recipients with Preformed Donor-Specific Antibodies (DSA), American Journal of Transplantation, vol.89, issue.1, pp.56-65, 2011.
DOI : 10.1111/j.1600-6143.2010.03364.x

M. Bettinotti, A. Zachary, and M. Leffell, Clinically relevant interpretation of solid phase assays for HLA antibody, Current Opinion in Organ Transplantation, vol.21, issue.4, pp.453-461, 2016.
DOI : 10.1097/MOT.0000000000000326

A. Sicard, S. Ducreux, M. Rabeyrin, L. Couzi, B. Mcgregor et al., Detection of C3d-Binding Donor-Specific Anti-HLA Antibodies at Diagnosis of Humoral Rejection Predicts Renal Graft Loss, Journal of the American Society of Nephrology, vol.26, issue.2, pp.457-67, 2015.
DOI : 10.1681/ASN.2013101144

A. Loupy, C. Lefaucheur, D. Vernerey, C. Prugger, J. Duong-van-huyen et al., Complement-Binding Anti-HLA Antibodies and Kidney-Allograft Survival, New England Journal of Medicine, vol.369, issue.13, pp.1215-1241, 2013.
DOI : 10.1056/NEJMoa1302506

B. Tait, C. Susal, H. Gebel, P. Nickerson, A. Zachary et al., Consensus Guidelines on the Testing and Clinical Management Issues Associated With HLA and Non-HLA Antibodies in Transplantation, Transplantation Journal, vol.95, issue.1, pp.19-47, 2013.
DOI : 10.1097/TP.0b013e31827a19cc

M. Mujtaba, W. Goggins, A. Lobashevsky, A. Sharfuddin, M. Yaqub et al., The strength of donor-specific antibody is a more reliable predictor of antibody-mediated rejection than flow cytometry crossmatch analysis in desensitized kidney recipients, Clinical Transplantation, vol.69, issue.Suppl 1, pp.96-102, 2011.
DOI : 10.1111/j.1399-0012.2010.01341.x

P. Gombos, G. Opelz, S. Scherer, C. Morath, M. Zeier et al., Superiority of AbCross Enzyme-Linked Immunosorbent Assay Cross-Match Over the B-Cell Complement-Dependent Lymphocytotoxicity Cross-Match, Transplantation Proceedings, vol.45, issue.4, pp.1383-1388, 2013.
DOI : 10.1016/j.transproceed.2013.01.039

G. Guidicelli, F. Guerville, S. Lepreux, C. Wiebe, O. Thaunat et al., Non-Complement-Binding De Novo Donor-Specific Anti-HLA Antibodies and Kidney Allograft Survival, Journal of the American Society of Nephrology, vol.27, issue.2, pp.615-640, 2016.
DOI : 10.1681/ASN.2014040326

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4731103

S. Mohan, A. Palanisamy, D. Tsapepas, B. Tanriover, R. Crew et al., Donor-Specific Antibodies Adversely Affect Kidney Allograft Outcomes, Journal of the American Society of Nephrology, vol.23, issue.12, pp.2061-71, 2012.
DOI : 10.1681/ASN.2012070664

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3507372

G. Bartel, H. Regele, M. Wahrmann, N. Huttary, M. Exner et al., Posttransplant HLA Alloreactivity in Stable Kidney Transplant Recipients-Incidences and Impact on Long-Term Allograft Outcomes, American Journal of Transplantation, vol.76, issue.12, 2008.
DOI : 10.1111/j.1600-6143.2008.02428.x

R. Hachem and N. Reinsmoen, What is the Definition of a Clinically Relevant Donor HLA-Specific Antibody (DSA)?, American Journal of Transplantation, vol.72, issue.2, pp.299-300, 2015.
DOI : 10.1111/ajt.13079

R. Frank, P. Lal, J. Kearns, M. Molina, J. Wald et al., Correlation of Circulating Complement-Fixing Donor-Specific Antibodies Identified by the C1q Assay and Presence of C4d in Endomyocardial Biopsy Specimens, American Journal of Clinical Pathology, vol.145, issue.1, pp.62-70, 2016.
DOI : 10.1093/ajcp/aqv016

T. Strom, N. Tilney, C. Carpenter, and G. Busch, Identity and Cytotoxic Capacity of Cells Infiltrating Renal Allografts, New England Journal of Medicine, vol.292, issue.24, pp.1257-63, 1975.
DOI : 10.1056/NEJM197506122922402

J. Fishman, What's New and What's Hot? Basic Science at the American Transplant Congress 2012, American Journal of Transplantation, vol.19, issue.Suppl 3, pp.275-80, 2013.
DOI : 10.1111/ajt.12015

T. Bachelet, L. Couzi, V. Pitard, X. Sicard, C. Rigothier et al., Cytomegalovirus-Responsive ???? T Cells: Novel Effector Cells in Antibody-Mediated Kidney Allograft Microcirculation Lesions, Journal of the American Society of Nephrology, vol.25, issue.11, pp.2471-82, 2014.
DOI : 10.1681/ASN.2013101052

M. Crespo, J. Yelamos, D. Redondo, A. Muntasell, M. Perez-saez et al., Circulating NK-Cell Subsets in Renal Allograft Recipients With Anti-HLA Donor-Specific Antibodies, American Journal of Transplantation, vol.79, issue.3, pp.806-820, 2015.
DOI : 10.1111/ajt.13010

T. Resch, C. Fabritius, S. Ebner, P. Ritschl, and K. Kotsch, The Role of Natural Killer Cells in Humoral Rejection, Transplantation, vol.99, issue.7, pp.1335-1375, 2015.
DOI : 10.1097/TP.0000000000000757

Z. Zhang, X. Huang, J. Jiang, A. Lau, Z. Yin et al., Natural Killer Cells Mediate Long-term Kidney Allograft Injury, Transplantation, vol.99, issue.5, pp.916-940, 2015.
DOI : 10.1097/TP.0000000000000665

S. Maier, C. Tertilt, N. Chambron, K. Gerauer, N. Huser et al., Inhibition of natural killer cells results in acceptance of cardiac allografts in CD28-/-mice, Nature Medicine, vol.7, issue.5, pp.557-621087880, 1038.
DOI : 10.1038/87880

E. Farkash and R. Colvin, Pathology: Diagnostic challenges in chronic antibody-mediated rejection, Nature Reviews Nephrology, vol.9, issue.5, pp.255-761, 2012.
DOI : 10.1038/nrneph.2012.61

T. Hirohashi, C. Chase, D. Pelle, P. Sebastian, D. Alessandrini et al., A Novel Pathway of Chronic Allograft Rejection Mediated by NK Cells and Alloantibody, American Journal of Transplantation, vol.27, issue.2, pp.313-334, 2012.
DOI : 10.1111/j.1600-6143.2011.03836.x

N. Kohei, T. Tanaka, K. Tanabe, N. Masumori, N. Dvorina et al., Natural killer cells play a critical role in mediating??inflammation and graft failure during antibody-mediated rejection of kidney allografts, Kidney International, vol.89, issue.6, pp.1293-306, 2016.
DOI : 10.1016/j.kint.2016.02.030

L. Hidalgo, B. Sis, J. Sellares, P. Campbell, M. Mengel et al., NK Cell Transcripts and NK Cells in Kidney Biopsies from Patients with Donor-Specific Antibodies: Evidence for NK Cell Involvement in Antibody-Mediated Rejection, American Journal of Transplantation, vol.6, issue.8, pp.1812-1834, 2010.
DOI : 10.1111/j.1600-6143.2010.03201.x

L. Hidalgo, J. Sellares, B. Sis, M. Mengel, J. Chang et al., Interpreting NK Cell Transcripts Versus T Cell Transcripts in Renal Transplant Biopsies, American Journal of Transplantation, vol.7, issue.10, pp.1180-91, 2012.
DOI : 10.1111/j.1600-6143.2011.03970.x

A. Loupy, C. Lefaucheur, D. Vernerey, J. Chang, L. Hidalgo et al., Molecular Microscope Strategy to Improve Risk Stratification in Early Antibody-Mediated Kidney Allograft Rejection, Journal of the American Society of Nephrology, vol.25, issue.10, pp.2267-77, 2014.
DOI : 10.1681/ASN.2013111149

R. Gill, NK cells: elusive participants in transplantation immunity and tolerance, Current Opinion in Immunology, vol.22, issue.5, pp.649-54, 2010.
DOI : 10.1016/j.coi.2010.09.005

J. Venner, L. Hidalgo, K. Famulski, J. Chang, and P. Halloran, The Molecular Landscape of Antibody-Mediated Kidney Transplant Rejection: Evidence for NK Involvement Through CD16a Fc Receptors, American Journal of Transplantation, vol.19, issue.5, pp.1336-1384, 2015.
DOI : 10.1111/ajt.13115

L. Couzi, V. Pitard, X. Sicard, I. Garrigue, O. Hawchar et al., Antibody-dependent anti-cytomegalovirus activity of human ???? T cells expressing CD16 (Fc??RIIIa), Blood, vol.119, issue.6, pp.1418-1445, 2012.
DOI : 10.1182/blood-2011-06-363655

S. Veeramani, S. Wang, C. Dahle, S. Blackwell, L. Jacobus et al., Rituximab infusion induces NK activation in lymphoma patients with the high-affinity CD16 polymorphism, Blood, vol.118, issue.12, pp.3347-3356, 2011.
DOI : 10.1182/blood-2011-05-351411

E. Hatjiharissi, L. Xu, D. Santos, Z. Hunter, B. Ciccarelli et al., Increased natural killer cell expression of CD16, augmented binding and ADCC activity to rituximab among individuals expressing the Fc??RIIIa-158 V/V and V/F polymorphism, Blood, vol.110, issue.7, pp.2561-2565, 2007.
DOI : 10.1182/blood-2007-01-070656

S. Shimizu, Y. Tanaka, H. Tazawa, S. Verma, T. Onoe et al., Fc-Gamma Receptor Polymorphisms Predispose Patients to Infectious Complications After Liver Transplantation, American Journal of Transplantation, vol.5, issue.2, pp.625-658, 2016.
DOI : 10.1111/ajt.13492

C. Neudoerfl, B. Mueller, C. Blume, K. Daemen, M. Stevanovic-meyer et al., The Peripheral NK Cell Repertoire after Kidney Transplantation is Modulated by Different Immunosuppressive Drugs, Frontiers in Immunology, vol.4, 2013.
DOI : 10.3389/fimmu.2013.00046

H. Vacher-coponat, C. Brunet, V. Moal, A. Loundou, E. Bonnet et al., Tacrolimus/Mycophenolate Mofetil Improved Natural Killer Lymphocyte Reconstitution One Year After Kidney Transplant by Reference to Cyclosporine/Azathioprine, Transplantation, vol.82, issue.4, pp.558-66, 2006.
DOI : 10.1097/01.tp.0000229390.01369.4a

H. Vacher-coponat, C. Brunet, L. Lyonnet, E. Bonnet, A. Loundou et al., Natural killer cell alterations correlate with loss of renal function and dialysis duration in uraemic patients, Nephrology Dialysis Transplantation, vol.23, issue.4, pp.1406-1420, 2008.
DOI : 10.1093/ndt/gfm596

O. Morteau, S. Blundell, A. Chakera, S. Bennett, C. Christou et al., Renal Transplant Immunosuppression Impairs Natural Killer Cell Function In Vitro and In Vivo, PLoS ONE, vol.82, issue.10, 2010.
DOI : 10.1371/journal.pone.0013294.s005

K. Hadaya, C. De-rham, C. Bandelier, S. Ferrari-lacraz, S. Jendly et al., Natural Killer Cell Receptor Repertoire and Their Ligands, and the Risk of CMV Infection After Kidney Transplantation, American Journal of Transplantation, vol.99, issue.Suppl 1, pp.2674-83, 2008.
DOI : 10.1111/j.1600-6143.2008.02431.x

B. Shin, S. Ge, J. Mirocha, A. Karasyov, A. Vo et al., Regulation of Anti-HLA Antibody-Dependent Natural Killer Cell Activation by Immunosuppressive Agents, Transplantation Journal, vol.97, issue.3, 2014.
DOI : 10.1097/01.TP.0000438636.52085.50

H. Vacher-coponat, V. Moal, M. Indreies, R. Purgus, A. Loundou et al., A Randomized Trial With Steroids and Antithymocyte Globulins Comparing Cyclosporine/Azathioprine Versus Tacrolimus/Mycophenolate Mofetil (CATM2) in Renal Transplantation, Transplantation, vol.93, issue.4, pp.437-480, 2012.
DOI : 10.1097/TP.0b013e31824215b7

D. Wettstein, G. Opelz, and C. Susal, HLA antibody screening in kidney transplantation: current guidelines, Langenbeck's Archives of Surgery, vol.3, issue.4, pp.415-435, 2014.
DOI : 10.1007/s00423-013-1138-6

M. Haas, B. Sis, L. Racusen, K. Solez, D. Glotz et al., Banff 2013 Meeting Report: Inclusion of C4d-Negative Antibody-Mediated Rejection and Antibody-Associated Arterial Lesions, American Journal of Transplantation, vol.17, issue.2, pp.272-83, 2014.
DOI : 10.1111/ajt.12590

B. Sis, G. Jhangri, J. Riopel, J. Chang, D. De-freitas et al., A New Diagnostic Algorithm for Antibody-Mediated Microcirculation Inflammation in Kidney Transplants, American Journal of Transplantation, vol.89, issue.5, pp.1168-79, 2012.
DOI : 10.1111/j.1600-6143.2011.03931.x

M. Banasik, M. Boratynska, K. Koscielska-kasprzak, D. Kaminska, D. Bartoszek et al., The influence of non-HLA antibodies directed against angiotensin II type 1 receptor (AT1R) on early renal transplant outcomes, Transplant International, vol.25, issue.10, pp.1029-1067, 2014.
DOI : 10.1111/tri.12371

P. Sood and S. Hariharan, Transplantation: Rituximab induction for prevention of HLA-antibody rebound, Nature Reviews Nephrology, vol.10, issue.12, 2014.
DOI : 10.1016/j.trim.2010.06.005

L. Rostaing and N. Kamar, Can we prevent donor-specific antibodies from developing after ABO-incompatible kidney transplantation?, Kidney International, vol.85, issue.2, pp.245-252, 2014.
DOI : 10.1038/ki.2013.425

G. Vidarsson, G. Dekkers, and T. Rispens, IgG Subclasses and Allotypes: From Structure to Effector Functions, Frontiers in Immunology, vol.66, issue.8, 2014.
DOI : 10.1111/j.1398-9995.2011.02579.x

URL : http://doi.org/10.3389/fimmu.2014.00520

A. Pincetic, S. Bournazos, D. Dilillo, J. Maamary, T. Wang et al., Type I and type II Fc receptors regulate innate and adaptive immunity, Nature Immunology, vol.6, issue.8, pp.707-723, 2014.
DOI : 10.1002/eji.201142260

C. Kellner, S. Derer, T. Valerius, and M. Peipp, Boosting ADCC and CDC activity by Fc engineering and evaluation of antibody effector functions, Methods, vol.65, issue.1, 2014.
DOI : 10.1016/j.ymeth.2013.06.036

Y. Mishima, Y. Terui, R. Kuniyoshi, S. Matsusaka, M. Mikuniya et al., High reproducible ADCC analysis revealed a competitive relation between ADCC and CDC and differences between Fc??Rllla polymorphism, International Immunology, vol.24, issue.8, pp.477-83, 2012.
DOI : 10.1093/intimm/dxs048

URL : http://intimm.oxfordjournals.org/cgi/content/short/24/8/477